UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

The New England journal of medicine, 2021-04, Vol.384 (13), p.1216-1226

2021

Volltextzugriff (PDF)

Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk

Journal of the American College of Cardiology, 1995-04, Vol.25 (5), p.1056-1062

1995

Volltextzugriff (PDF)

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

Nature genetics, 2009-12, Vol.41 (12), p.1345-1349

2009

Volltextzugriff (PDF)

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

Nature genetics, 2015-09, Vol.47 (9), p.1079-1084

2015

Volltextzugriff (PDF)

Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group

Clinical pharmacology and therapeutics, 2015-09, Vol.98 (3), p.266-287

2015

Volltextzugriff (PDF)

Drug‐induced acute kidney injury in children

British journal of clinical pharmacology, 2015-10, Vol.80 (4), p.901-909

2015

Volltextzugriff (PDF)

Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children

Pharmacogenomics, 2015-07, Vol.16 (10), p.1065-1076

2015

Volltextzugriff (PDF)

Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children

Pediatric blood & cancer, 2013-08, Vol.60 (8), p.1375-1381

2013

Volltextzugriff (PDF)

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children

Clinical pharmacology and therapeutics, 2013-08, Vol.94 (2), p.243-251

2013

Volltextzugriff (PDF)

The Predictive Value of the In Vitro Platelet Toxicity Assay (iPTA) for the Diagnosis of Hypersensitivity Reactions to Sulfonamides

Journal of clinical pharmacology, 2013-06, Vol.53 (6), p.626-632

2013

Volltextzugriff (PDF)

Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions

Pediatrics (Evanston), 2010-10, Vol.126 (4), p.e986

2010

Volltextzugriff (PDF)

Oral morphine dosing predictions based on single dose in healthy children undergoing surgery

Pediatric anesthesia, 2017-01, Vol.27 (1), p.28-36

2017

Volltextzugriff (PDF)

The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology

Thyroid (New York, N.Y.), 2010-07, Vol.20 (7), p.681

2010

Volltextzugriff (PDF)

Type‐specific clinical characteristics of adenovirus‐associated influenza‐like illness at five US military medical centers, 2009–2014

Influenza and other respiratory viruses, 2016-09, Vol.10 (5), p.414-420

2016

Volltextzugriff (PDF)

N-acetylcysteine as a Novel Prophylactic Treatment for Ifosfamide-Induced Nephrotoxicity in Children: Translational Pharmacokinetics

Journal of clinical pharmacology, 2012-01, Vol.52 (1), p.55-64

2012

Volltextzugriff (PDF)

The In Vitro Platelet Toxicity Assay (iPTA): A Novel Approach for Assessment of Drug Hypersensitivity Syndrome

Journal of clinical pharmacology, 2011-03, Vol.51 (3), p.428-435

2011

Volltextzugriff (PDF)

N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide

Journal of population therapeutics and clinical pharmacology, 2013, Vol.20 (2), p.e132-e145

2013

Volltextzugriff (PDF)

Pharmacogenomics and active surveillance for serious adverse drug reactions in children

Pharmacogenomics, 2010-09, Vol.11 (9), p.1269-1285

2010

Volltextzugriff (PDF)

Pharmacological Risk Factors for Amphotericin B Nephrotoxicity in Children

Journal of clinical pharmacology, 2007-08, Vol.47 (8), p.1049-1054

2007

Volltextzugriff (PDF)

Severe bullous hypersensitivity reactions after exposure to carbamazepine in a Han-Chinese child with a positive HLA-B1502 and negative in vitro toxicity assays: evidence for different pathophysiological mechanisms

Journal of population therapeutics and clinical pharmacology, 2011, Vol.18 (1), p.e1-e9

2011

Volltextzugriff (PDF)

Management of splenic trauma in the pediatric hemophiliac patient: Case series and review of the literature

Journal of pediatric surgery, 2002-04, Vol.37 (4), p.568-571

2002

Volltextzugriff (PDF)

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children

Clinical pharmacology and therapeutics, 2013-07, Vol.94 (1), p.142

2013

Volltextzugriff (PDF)

Ambient ozone causes upper airways inflammation in children

The American review of respiratory disease, 1993-10, Vol.148 (4 Pt 1), p.961

1993

Volltextzugriff (PDF)

Management of Kawasaki syndrome: a consensus statement prepared by North American participants of The Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988

The Pediatric infectious disease journal, 1989-10, Vol.8 (10), p.663-667

1989

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

KollektionSpringer journals

ThemaChild

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group

Drug‐induced acute kidney injury in children

Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children

Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children

The Predictive Value of the In Vitro Platelet Toxicity Assay (iPTA) for the Diagnosis of Hypersensitivity Reactions to Sulfonamides

Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions

Oral morphine dosing predictions based on single dose in healthy children undergoing surgery

The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology

Type‐specific clinical characteristics of adenovirus‐associated influenza‐like illness at five US military medical centers, 2009–2014

N-acetylcysteine as a Novel Prophylactic Treatment for Ifosfamide-Induced Nephrotoxicity in Children: Translational Pharmacokinetics

The In Vitro Platelet Toxicity Assay (iPTA): A Novel Approach for Assessment of Drug Hypersensitivity Syndrome

N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide

Pharmacogenomics and active surveillance for serious adverse drug reactions in children

Pharmacological Risk Factors for Amphotericin B Nephrotoxicity in Children

Severe bullous hypersensitivity reactions after exposure to carbamazepine in a Han-Chinese child with a positive HLA-B1502 and negative in vitro toxicity assays: evidence for different pathophysiological mechanisms

Management of splenic trauma in the pediatric hemophiliac patient: Case series and review of the literature

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children

Ambient ozone causes upper airways inflammation in children

Management of Kawasaki syndrome: a consensus statement prepared by North American participants of The Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988

Aktive Filter

Suchergebnisse filtern